Fiskars opens design exhibition to celebrate iconic Orange-handled Scissors’ 50th anniversary
Fiskars, the World’s #1 Scissors Brand™, celebrates the 50th anniversary of its famous Orange-handled Scissors™ by launching an exhibition at the Helsinki Design Museum this month, showcasing artwork from prominent global personalities who use or are inspired by the scissors. Since their introduction as the first plastic-handled scissors in 1967, Fiskars has sold over one billion pairs worldwide.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170907006004/en/
The iconic orange color is a happy coincidence. The first scissors prototype was produced with the machine that manufactured Fiskars juicers, which utilized the same color orange. In the final vote, orange beat black by 9 votes to 7. The color orange is now an official trademark color of Fiskars and a visual indicator of the brand, signaling quality, durability and design. (Photo: Business Wire)
The exhibition will launch with a VIP event on Sept. 7 and will be open to the public from Sept. 8 – Oct. 29, 2017. Works inspired by the scissors will be displayed from fashion designers Tracy Reese, Katie Ermilio and Martin Bergström; paper artists Eloise Corr Danch, Karen Bit Vejle and JUDiTH+ROLFE; illustrator Laura Ljungkvist; Grace Bonney of the blog Design*Sponge; designer Tuula Pöyhönen; and Berliner art collective TAPE THAT.
"This exhibition is a celebration of the Scissors' role as a design classic that is used and recognized across the globe. We want to inspire the next 50 years,” said Vice President of Brand and Integrated Marketing at Fiskars, Marika Orkamo.
Fiskars has been celebrating the anniversary by collecting consumer stories from around the world via social media leading up to the anniversary date of October 5, 2017.
“Every pair of Orange-handled Scissors™ comes with its own story, whether it’s being told not to touch ‘mom’s scissors’ or passing them down for generations,” said President of Fiskars Global Functional, Paul Tonnesen. “What better way to honor the Orange-handled Scissors™ on this anniversary than to share these stories worldwide?”
To read more on the 50th anniversary of Orange-handled Scissors™ and the Helsinki Design Exhibit, or to share your story, please visit ourscissors.fiskars.com.
ABOUT FISKARS
Since its establishment in 1649, Fiskars Group has grown to be a leading functional and living products company with a strong brand portfolio, including Fiskars, Iittala, Gerber, Wedgewood and Waterford. Fiskars Group has employees in over 30 countries and is headquartered in Finland. With over 1 billion Orange-handled Scissors sold, Fiskars has grown to be the World’s #1 Scissors Brand. Fiskars promotes achievement and self-expression by focusing on easy to use, innovative tools to make gardening, cooking and crafting more enjoyable. Visit www.fiskars.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170907006004/en/
Contact information
Fiskars Americas
Blair Brophy
608-294-4532
blair.brophy@fiskars.com
or
Fiskars
Finland
Jessica Finnilä
+358 44 992 66 65
jessica.finnila@fiskars.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 23:32:00 EEST | Press release
Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management to fully concentrate on on-field performance, ensuring that collective focus remains on
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release
IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 15:00:00 EEST | Press release
HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #H
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom